0001104659-23-024293.txt : 20230222 0001104659-23-024293.hdr.sgml : 20230222 20230222160542 ACCESSION NUMBER: 0001104659-23-024293 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220225 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abernethy Amy CENTRAL INDEX KEY: 0001590728 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-40312 FILM NUMBER: 23653068 MAIL ADDRESS: STREET 1: 311 ARSENAL STREET CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EQRx, Inc. CENTRAL INDEX KEY: 0001843762 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 861691173 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6173152266 MAIL ADDRESS: STREET 1: 50 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: CM Life Sciences III Inc. DATE OF NAME CHANGE: 20210201 4/A 1 tm237528-1_4aseq1.xml OWNERSHIP DOCUMENT X0306 4/A 2022-02-25 2022-03-01 0 0001843762 EQRx, Inc. EQRX 0001590728 Abernethy Amy EQRX, INC. 50 HAMPSHIRE STREET CAMBRIDGE, MA 02139 1 0 0 0 Stock Option (Right to Buy) 3.03 2022-02-25 4 A 0 389223 0 A 2032-02-25 Common Stock 389223 389223 D This Form 4/A amends and restates the original Form 4 filed on March 1, 2022 (the "Original Form 4"). The number of shares of Common Stock subject to the stock option granted to the Reporting Person on February 25, 2022 was erroneously reported as 449,644 in the Original Form 4. One-third of the shares underlying this option shall vest and become exercisable on December 17, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date. /s/ William Collins, Attorney-in-Fact 2023-02-22